Global Coronary Stents Market is Expected to Reach $15.4 billion by 2030: AMR

Surge in the number of coronary artery diseases among people across the globe, impressive patient results with stenting, and persistent enhancements in coronary artery stents are expected to drive the growth of the global coronary stents market. Based on biomaterial, the metabolic biomaterial segment generated the highest market share in 2020. Based on region, Asia-Pacific is expected to exhibit the fastest CAGR by 2030.


Portland, OR, April 26, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Coronary Stents Market generated $8.8 billion in 2020, and is projected to reach $15.4 billion by 2030 registering a CAGR of 6% from 2021 to 2030. The report provides an in-depth analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive scenario, and wavering market trends.

Download Sample PDF at: https://www.alliedmarketresearch.com/request-sample/2187

Surge in the number of coronary artery diseases among people across the globe, impressive patient results with stenting, and persistent enhancements in coronary artery stents are expected to drive the growth of the global coronary stents market. On the other hand, extortionate cost of procedures related to coronary stents would hinder the growth to some extent. However, significant surge in the demand for coronary stents in developing countries is predicted to provide lucrative opportunities for the growth of the industry.

COVID-19 Scenario

  • The outbreak of COVID-19 has had a negative impact on the global coronary stents market, owing to the prevalence of lockdowns in various countries across the globe. The global lockdown adversely disrupted the workflow in the healthcare sector as most of the percutaneous coronary intervention (PCI) procedures were consequently shifted and delayed up to six months, thereby impacting the market negatively.
  • However, the market is expected to recoup soon.

The report offers a detailed segmentation of the global coronary stents market based on product, biomaterial, end-user and region.

Specific Requirement on COVID-19? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/2187

Based on product, the drug-eluting stents segment generated the highest market share in 2020, garnering nearly three-fourths of the global coronary stents market. The same segment is expected to cite the fastest CGAR of 6.45% during the forecast period.

Based on biomaterial, the metallic biomaterials held the majority market share in 2020, accounting for nearly three-fourths of the global coronary stents market. The natural biomaterial, on the other hand, is expected to exhibit the fastest CAGR of 7.31% during the forecast period.

Based on region, the market across North America held the lion’s share in 2020, garnering nearly two-fifths of the global coronary stents market. The Asia-Pacific region, on the other hand, is expected to cite the fastest CAGR of 6.7% during the forecast period.

The key players analyzed in the global coronary stents market report include Terumo Corporation, Medtronic plc., Biotronik SE & Co. KG, Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Biosensors International Group, Ltd., Elixir Medical Corporation, Becton Dickinson and Company, Microport Scientific Corporation.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

“We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market.”

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Ovarian Cancer Drugs Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Weight Loss and Obesity Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Facial Injectables Market - Global Opportunity Analysis and Industry Forecast, 2020-2028

Creatinine Measurement Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Neurotrophic Keratitis Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Animal Biotechnology Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Gait Trainer Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Complementary and Alternative Medicine Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Medical foods Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

Long Read Sequencing Market - Global Opportunity Analysis and Industry Forecast, 2020–2028

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact Data